What is NDC 67877-263?

67877-263 is the product NDC for Duloxetine, Duloxetine hydrochloride 20 mg/1 capsule, delayed release, listed with the FDA by Ascend Laboratories, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Duloxetine?

140 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Duloxetine NDC 67877-263 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-263Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0263Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-263-01	6787702630167877026301	100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-263-01)Marketed from May 1, 2012
67877-263-10	6787702631067877026310	1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-263-10)Marketed from May 1, 2012
67877-263-30	6787702633067877026330	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-263-30)Marketed from May 1, 2012
67877-263-60	6787702636067877026360	60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-263-60)Marketed from May 1, 2012
67877-263-90	6787702639067877026390	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-263-90)Marketed from May 1, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Duloxetine
Generic name (nonproprietary): duloxetine
Active ingredients: Duloxetine hydrochloride — 20 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203197
Marketing start: May 1, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 67877-263_958fae45-5e7a-4f8b-80b7-5934222747b5SPL ID 958fae45-5e7a-4f8b-80b7-5934222747b5SPL set ID e6477c41-97a2-45a7-94b5-487aa65199f6RxCUI 596926, 596930, 596934UNII 9044SC542WUPC 0367877263106
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877026301 followed by a unit qualifier and the quantity

Package 67877-0263-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Duloxetine is indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults and pediatric patients 13 years of age and older Chronic musculoskeletal pain in adults Duloxetine hydrochloride is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major depressive disorder (MDD) in adults ( 1 ) Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 ) Diabetic peripheral neuropathic pain (DPNP) in adults ( 1 ) Fibromyalgia (FM) in adu…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-263

What is NDC 67877-263?: 67877-263 is the product NDC for Duloxetine, Duloxetine hydrochloride 20 mg/1 capsule, delayed release, listed with the FDA by Ascend Laboratories, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Duloxetine.
What is the active ingredient?: Duloxetine hydrochloride.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Duloxetine?: 140 other product NDCs are listed under this name. See all Duloxetine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Duloxetine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Duloxetine	Duloxetine hydrochloride 20 mg/1	Capsule, Delayed releaseOral	ANI Pharmaceuticals, Inc.	70954-860	70954-0860-30
Duloxetine	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed releaseOral	ANI Pharmaceuticals, Inc.	70954-861	70954-0861-20
Duloxetine	Duloxetine hydrochloride 60 mg/1	Capsule, Delayed releaseOral	ANI Pharmaceuticals, Inc.	70954-864	70954-0864-20
Duloxetine	Duloxetine hydrochloride 120 mg/1	Capsule, Delayed releaseOral	Almatica Pharma LLC	52427-791	52427-0791-30
Duloxetine	Duloxetine hydrochloride 80 mg/1	Capsule, Delayed releaseOral	Almatica Pharma LLC	52427-821	52427-0821-30
Duloxetine	Duloxetine hydrochloride 90 mg/1	Capsule, Delayed releaseOral	Almatica Pharma LLC	52427-913	52427-0913-30
Duloxetine	Duloxetine hydrochloride 20 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-4128	68788-4128-0368788-4128-0668788-4128-09
Duloxetine	Duloxetine hydrochloride 60 mg/1	Capsule, Delayed releaseOral	Coupler LLC	67046-1598	67046-1598-03
Duloxetine	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed releaseOral	Coupler LLC	67046-1585	67046-1585-03
Duloxetine	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed release pelletsOral	Preferred Phamaceuticals Inc.	68788-4025	68788-4025-0368788-4025-0668788-4025-09

All 141 Duloxetine NDCs

Other NDCs under ANDA 203197

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203197
Product	Strength	Form · route	Labeler	Product NDC
Duloxetine	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed releaseOral	Ascend Laboratories, LLC	67877-264
Duloxetine	Duloxetine hydrochloride 60 mg/1	Capsule, Delayed releaseOral	Ascend Laboratories, LLC	67877-265
Duloxetine	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed releaseOral	Proficient Rx LP	71205-445
Duloxetine	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-1672
Duloxetine HCL DRduloxetine hcl	Duloxetine hydrochloride 30 mg/1	Capsule, Delayed releaseOral	Advanced Rx of Tennessee, LLC	80425-0012